2
项与 Allogeneic Endothelial Progenitor Cells(Allife Medical Science and Technology) 相关的临床试验Phase I Clinical Study on the Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) Injection in Patients With Critical Limb Ischemia
The purpose of this study is to determine if allogeneic Endothelial Progenitor Cells (EPCs) intravenous infusion to a subject with leg ulcer and/or gangrene due to poor blood flow will be safe and if it will relieve leg pain, increase blood flow, and/or cure the leg wound.
Phase I Clinical Study on the Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) Injection in Patients With Acute Ischemic Stroke
This is a single center, randomized, double-blind, placebo-controlled, dose-Escalation clinical study to investigate the safety and efficacy of EPCs transplantation in Acute ischemic stroke.
100 项与 Allogeneic Endothelial Progenitor Cells(Allife Medical Science and Technology) 相关的临床结果
100 项与 Allogeneic Endothelial Progenitor Cells(Allife Medical Science and Technology) 相关的转化医学
100 项与 Allogeneic Endothelial Progenitor Cells(Allife Medical Science and Technology) 相关的专利(医药)
100 项与 Allogeneic Endothelial Progenitor Cells(Allife Medical Science and Technology) 相关的药物交易